Steve Weller

699 total citations
9 papers, 295 citations indexed

About

Steve Weller is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Steve Weller has authored 9 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Steve Weller's work include HIV/AIDS drug development and treatment (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Steve Weller is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Steve Weller collaborates with scholars based in United States, Netherlands and India. Steve Weller's co-authors include Gary E. Pakes, Geoffrey J. Yuen, Stuart Gibson, Brett Ninness, Olivier Bourdon, E Singlas, Roselyne Bidault, Laurie Sherman, Michael J. Keating and S. Swann and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Pharmacokinetics and European Journal of Clinical Pharmacology.

In The Last Decade

Steve Weller

8 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steve Weller United States	7	87	81	46	44	44	9	295
Rebecca Pavlos Australia	15	79 0.9×	55 0.7×	70 1.5×	61 1.4×	28 0.6×	24	882
Lawrence Galitz United States	8	87 1.0×	74 0.9×	149 3.2×	19 0.4×	114 2.6×	12	480
James Geib United States	10	70 0.8×	100 1.2×	71 1.5×	17 0.4×	57 1.3×	21	401
Olga Millán Spain	18	110 1.3×	142 1.8×	159 3.5×	93 2.1×	72 1.6×	46	852
Jianhui Fan China	11	44 0.5×	102 1.3×	80 1.7×	45 1.0×	35 0.8×	23	446
Ali Nassif France	13	48 0.6×	98 1.2×	102 2.2×	51 1.2×	87 2.0×	29	452
Abbe Rubin United States	10	38 0.4×	87 1.1×	62 1.3×	12 0.3×	70 1.6×	13	563
Geneviève Laflamme United States	14	336 3.9×	230 2.8×	105 2.3×	43 1.0×	63 1.4×	18	583
Sauzanne Khalilieh United States	17	284 3.3×	73 0.9×	108 2.3×	80 1.8×	126 2.9×	32	802
Sepideh Akhavan France	13	63 0.7×	78 1.0×	87 1.9×	17 0.4×	11 0.3×	29	631

Countries citing papers authored by Steve Weller

Since Specialization

Citations

This map shows the geographic impact of Steve Weller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Weller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Weller more than expected).

Fields of papers citing papers by Steve Weller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Weller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Weller. The network helps show where Steve Weller may publish in the future.

Co-authorship network of co-authors of Steve Weller

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Weller. A scholar is included among the top collaborators of Steve Weller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Weller. Steve Weller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Bandara, Priyanka, et al.. (2020). 5G wireless deployment and health risks: Time for a medical discussion in Australia and New Zealand. 39(2). 27.

2.

Song, Ivy, et al.. (2016). Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation. European Journal of Clinical Pharmacology. 72(6). 665–670. 23 indexed citations

3.

Lou, Yu, Amanda Peppercorn, Elizabeth Gould, et al.. (2013). Effect of Intravenous Zanamivir on Cardiac Repolarization. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(7). 701–709. 3 indexed citations

4.

Plummer, Ruth, Ayman Madi, Heike Richly, et al.. (2012). A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(1). 93–101. 25 indexed citations

5.

Shapiro, Geoffrey I., Stewart W. McCallum, Laurel M. Adams, et al.. (2012). A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors. Investigational New Drugs. 31(3). 742–750. 38 indexed citations

6.

Yuen, Geoffrey J., Steve Weller, & Gary E. Pakes. (2008). A Review of the Pharmacokinetics of Abacavir. Clinical Pharmacokinetics. 47(6). 351–371. 110 indexed citations

7.

Bourdon, Olivier, et al.. (2004). Evaluation of Pharmacokinetic Interactions After Oral Administration of Mycophenolate Mofetil and Valaciclovir or Aciclovir to Healthy Subjects. Clinical Pharmacokinetics. 43(10). 685–692. 36 indexed citations

8.

Gandhi, Varsha, William Plunkett, Steve Weller, et al.. (2001). Evaluation of the Combination of Nelarabine and Fludarabine in Leukemias: Clinical Response, Pharmacokinetics, and Pharmacodynamics in Leukemia Cells. Journal of Clinical Oncology. 19(8). 2142–2152. 45 indexed citations

9.

Ninness, Brett, Stuart Gibson, & Steve Weller. (2000). Practical Aspects of Using Orthonormal System Parameterisations in Estimation Problems. IFAC Proceedings Volumes. 33(15). 463–468. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact